American Heart Journal, ISSN 0002-8703, 2008, Volume 155, Issue 3, pp. 499.e1 - 499.e8
Background Contrast media cause oxidative stress, which has been suggested as one possible mechanism responsible for contrast-induced nephropathy. Statins...
Cardiovascular | AGENT | INTERVENTIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | STATIN THERAPY | IODIXANOL | N-ACETYLCYSTEINE | TOXICITY | CONTRAST-INDUCED NEPHROPATHY | FAILURE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Male | Coronary Angiography - adverse effects | Renal Insufficiency - prevention & control | Renal Insufficiency - epidemiology | Incidence | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Renal Insufficiency - chemically induced | Time Factors | Coronary Disease - complications | Female | Renal Insufficiency - complications | Korea - epidemiology | Double-Blind Method | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Treatment Outcome | Coronary Disease - diagnostic imaging | Aged | Triiodobenzoic Acids - adverse effects | Prevention | Medical research | Care and treatment | Kidney failure | Simvastatin | Clinical trials | Medicine, Experimental | Contrast media | Studies | Contrast agents | Medical imaging | Free radicals | Mortality | Intubation | Diabetes | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Cardiovascular | AGENT | INTERVENTIONS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | STATIN THERAPY | IODIXANOL | N-ACETYLCYSTEINE | TOXICITY | CONTRAST-INDUCED NEPHROPATHY | FAILURE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Male | Coronary Angiography - adverse effects | Renal Insufficiency - prevention & control | Renal Insufficiency - epidemiology | Incidence | Dose-Response Relationship, Drug | Contrast Media - adverse effects | Renal Insufficiency - chemically induced | Time Factors | Coronary Disease - complications | Female | Renal Insufficiency - complications | Korea - epidemiology | Double-Blind Method | Administration, Oral | Simvastatin - administration & dosage | Risk Factors | Treatment Outcome | Coronary Disease - diagnostic imaging | Aged | Triiodobenzoic Acids - adverse effects | Prevention | Medical research | Care and treatment | Kidney failure | Simvastatin | Clinical trials | Medicine, Experimental | Contrast media | Studies | Contrast agents | Medical imaging | Free radicals | Mortality | Intubation | Diabetes | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2012, Volume 5, Issue 1, pp. 90 - 97
This study investigated the effect of furosemide-forced diuresis and intravenous saline infusion matched with urine output, using a novel dedicated device...
furosemide | contrast-induced nephropathy | percutaneous coronary intervention | high urine output | hydration | SODIUM-BICARBONATE | CARDIAC & CARDIOVASCULAR SYSTEMS | SALINE HYDRATION | ACUTE-RENAL-FAILURE | PREDICTION | Creatinine | Fluid Therapy | Confidence Intervals | Prospective Studies | Kidney Diseases - prevention & control | Humans | Risk Factors | Male | Statistics as Topic | Acute Kidney Injury - prevention & control | Hydrotherapy - methods | Furosemide - therapeutic use | Contrast Media - adverse effects | Time Factors | Acute Kidney Injury - complications | Kidney Diseases - chemically induced | Statistics, Nonparametric | Diuretics - therapeutic use | Female | Acute Kidney Injury - chemically induced | Aged | Kidney Diseases - complications
furosemide | contrast-induced nephropathy | percutaneous coronary intervention | high urine output | hydration | SODIUM-BICARBONATE | CARDIAC & CARDIOVASCULAR SYSTEMS | SALINE HYDRATION | ACUTE-RENAL-FAILURE | PREDICTION | Creatinine | Fluid Therapy | Confidence Intervals | Prospective Studies | Kidney Diseases - prevention & control | Humans | Risk Factors | Male | Statistics as Topic | Acute Kidney Injury - prevention & control | Hydrotherapy - methods | Furosemide - therapeutic use | Contrast Media - adverse effects | Time Factors | Acute Kidney Injury - complications | Kidney Diseases - chemically induced | Statistics, Nonparametric | Diuretics - therapeutic use | Female | Acute Kidney Injury - chemically induced | Aged | Kidney Diseases - complications
Journal Article
Circulation, ISSN 0009-7322, 07/2012, Volume 126, Issue 3, pp. 296 - 303
Background-Contrast medium-induced acute kidney injury is associated with substantial morbidity and mortality. The underlying mechanism has been attributed in...
contrast-induced nephropathy | chronic kidney disease | coronary angiography | prevention | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | N-ACETYLCYSTEINE | GELATINASE-ASSOCIATED LIPOCALIN | FAILURE | SERUM CREATININE | ACUTE MYOCARDIAL-INFARCTION | CARDIAC-CATHETERIZATION | CYSTATIN-C | PERIPHERAL VASCULAR DISEASE | CORONARY INTERVENTION | Heart Valve Prosthesis Implantation | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Coronary Angiography - adverse effects | Glomerular Filtration Rate - physiology | Incidence | Ischemic Preconditioning - methods | Contrast Media - adverse effects | Coronary Angiography - methods | Aged, 80 and over | Female | Acute Kidney Injury - chemically induced | Risk Factors | Blood Pressure Monitors | Acute Kidney Injury - prevention & control | Morbidity | Acute Kidney Injury - mortality | Pilot Projects | Heart Diseases - mortality | Coronary Artery Bypass | Creatinine - blood | Arm - blood supply | Aged | Heart Diseases - diagnostic imaging | Heart Diseases - surgery | Prevention | Usage | Prognosis | Kidney diseases | Health aspects | Contrast media
contrast-induced nephropathy | chronic kidney disease | coronary angiography | prevention | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | N-ACETYLCYSTEINE | GELATINASE-ASSOCIATED LIPOCALIN | FAILURE | SERUM CREATININE | ACUTE MYOCARDIAL-INFARCTION | CARDIAC-CATHETERIZATION | CYSTATIN-C | PERIPHERAL VASCULAR DISEASE | CORONARY INTERVENTION | Heart Valve Prosthesis Implantation | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Coronary Angiography - adverse effects | Glomerular Filtration Rate - physiology | Incidence | Ischemic Preconditioning - methods | Contrast Media - adverse effects | Coronary Angiography - methods | Aged, 80 and over | Female | Acute Kidney Injury - chemically induced | Risk Factors | Blood Pressure Monitors | Acute Kidney Injury - prevention & control | Morbidity | Acute Kidney Injury - mortality | Pilot Projects | Heart Diseases - mortality | Coronary Artery Bypass | Creatinine - blood | Arm - blood supply | Aged | Heart Diseases - diagnostic imaging | Heart Diseases - surgery | Prevention | Usage | Prognosis | Kidney diseases | Health aspects | Contrast media
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 67, Issue 1, pp. 20 - 30
Mesoamerican nephropathy (MeN), an epidemic in Central America, is a chronic kidney disease of unknown cause. In this article, we argue that MeN may be a uric...
Nephrology | Central America | tubular injury | heat stress nephropathy | chronic kidney disease (CKD) | etiology | hyperuricemia | rhabdomyolysis | urinary acidification | uricosuria | uric acid disorder | uric acid crystalluria | sugarcane workers | physical exertion | dehydration | hypothesis | Mesoamerican nephropathy (MeN) | SODIUM-BICARBONATE | GLOMERULAR HYPERTENSION | WATER-INTAKE | CONTRAST-INDUCED NEPHROPATHY | ACUTE-RENAL-FAILURE | CENTRAL-AMERICA | CARDIAC-SURGERY | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | FRUCTOSE CONSUMPTION | PROXIMAL TUBULE | Uric Acid - urine | Heat Stress Disorders - etiology | Exercise | Renal Insufficiency, Chronic - etiology | Humans | Crystallization | Adult | Male | acute-renal-failure | sodium-bicarbonate | randomized controlled-trial | fructose | contrast-induced | consumption | Klinisk medicin | central-america | water-intake | Clinical Medicine | sugarcane harvesters | glomerular hypertension | nephropathy | chronic kidney-disease | chronic
Nephrology | Central America | tubular injury | heat stress nephropathy | chronic kidney disease (CKD) | etiology | hyperuricemia | rhabdomyolysis | urinary acidification | uricosuria | uric acid disorder | uric acid crystalluria | sugarcane workers | physical exertion | dehydration | hypothesis | Mesoamerican nephropathy (MeN) | SODIUM-BICARBONATE | GLOMERULAR HYPERTENSION | WATER-INTAKE | CONTRAST-INDUCED NEPHROPATHY | ACUTE-RENAL-FAILURE | CENTRAL-AMERICA | CARDIAC-SURGERY | UROLOGY & NEPHROLOGY | CHRONIC KIDNEY-DISEASE | FRUCTOSE CONSUMPTION | PROXIMAL TUBULE | Uric Acid - urine | Heat Stress Disorders - etiology | Exercise | Renal Insufficiency, Chronic - etiology | Humans | Crystallization | Adult | Male | acute-renal-failure | sodium-bicarbonate | randomized controlled-trial | fructose | contrast-induced | consumption | Klinisk medicin | central-america | water-intake | Clinical Medicine | sugarcane harvesters | glomerular hypertension | nephropathy | chronic kidney-disease | chronic
Journal Article
European Radiology, ISSN 0938-7994, 12/2011, Volume 21, Issue 12, pp. 2527 - 2541
The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced...
Renal insufficiency, chronic | Diagnostic Radiology | Iodine-based contrast media | Acute kidney injury | Internal Medicine | Gadolinium | Neuroradiology | Medicine & Public Health | Renal failure | Iodopyridones | Interventional Radiology | Metformin | Imaging / Radiology | Gadolinium-based contrast media | Ultrasound | Contrast media | Contrast-induced nephropathy | Contrast medium-induced nephropathy | SODIUM-BICARBONATE | CONSENSUS WORKING PANEL | AGENT-INDUCED NEPHROPATHY | LOW-OSMOLAR | N-ACETYLCYSTEINE | PERCUTANEOUS CORONARY INTERVENTIONS | GLOMERULAR-FILTRATION-RATE | HIGH-RISK PATIENTS | CHRONIC KIDNEY-DISEASE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHRONIC-RENAL-FAILURE | Fluid Therapy | Gadolinium - administration & dosage | Glomerular Filtration Rate | Injections, Intravenous | Europe | Humans | Risk Factors | Male | Sodium Bicarbonate - administration & dosage | Sodium Chloride - administration & dosage | Coronary Angiography - adverse effects | Gadolinium - adverse effects | Renal Insufficiency - prevention & control | Contrast Media - adverse effects | Iodine - adverse effects | Renal Insufficiency - chemically induced | Renal Insufficiency - physiopathology | Coronary Angiography - methods | Iodine - administration & dosage | Contrast Media - administration & dosage | Female | Heart Failure - diagnostic imaging | Injections, Intra-Arterial | Practice Guidelines as Topic | Rare earth metals | Sodium bicarbonate | Kidney diseases | College teachers | Universities and colleges | Carbonates | Risk factors
Renal insufficiency, chronic | Diagnostic Radiology | Iodine-based contrast media | Acute kidney injury | Internal Medicine | Gadolinium | Neuroradiology | Medicine & Public Health | Renal failure | Iodopyridones | Interventional Radiology | Metformin | Imaging / Radiology | Gadolinium-based contrast media | Ultrasound | Contrast media | Contrast-induced nephropathy | Contrast medium-induced nephropathy | SODIUM-BICARBONATE | CONSENSUS WORKING PANEL | AGENT-INDUCED NEPHROPATHY | LOW-OSMOLAR | N-ACETYLCYSTEINE | PERCUTANEOUS CORONARY INTERVENTIONS | GLOMERULAR-FILTRATION-RATE | HIGH-RISK PATIENTS | CHRONIC KIDNEY-DISEASE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHRONIC-RENAL-FAILURE | Fluid Therapy | Gadolinium - administration & dosage | Glomerular Filtration Rate | Injections, Intravenous | Europe | Humans | Risk Factors | Male | Sodium Bicarbonate - administration & dosage | Sodium Chloride - administration & dosage | Coronary Angiography - adverse effects | Gadolinium - adverse effects | Renal Insufficiency - prevention & control | Contrast Media - adverse effects | Iodine - adverse effects | Renal Insufficiency - chemically induced | Renal Insufficiency - physiopathology | Coronary Angiography - methods | Iodine - administration & dosage | Contrast Media - administration & dosage | Female | Heart Failure - diagnostic imaging | Injections, Intra-Arterial | Practice Guidelines as Topic | Rare earth metals | Sodium bicarbonate | Kidney diseases | College teachers | Universities and colleges | Carbonates | Risk factors
Journal Article
Advances in Chronic Kidney Disease, ISSN 1548-5595, 05/2017, Volume 24, Issue 3, pp. 169 - 175
Contrast-induced nephropathy (CIN) has been considered to be a cause of renal failure for over 50 years, but careful review of past and recent studies reveals...
Contrast-Induced Nephropathy | Acute Kidney Injury | SERUM CREATININE | ENHANCED COMPUTED-TOMOGRAPHY | HOSPITALIZED-PATIENTS | HIGH-OSMOLALITY | UROLOGY & NEPHROLOGY | MEDIA | INDUCED NEPHROTOXICITY | FAILURE | CREATININE CLEARANCE | RENAL-INSUFFICIENCY | Administration, Intravenous | Contrast Media - adverse effects | Osmolar Concentration | Risk Assessment | Contrast Media - administration & dosage | Humans | Kidney Diseases - chemically induced | Contrast Media - chemistry | Research Design - standards | Control Groups | Angiocardiography
Contrast-Induced Nephropathy | Acute Kidney Injury | SERUM CREATININE | ENHANCED COMPUTED-TOMOGRAPHY | HOSPITALIZED-PATIENTS | HIGH-OSMOLALITY | UROLOGY & NEPHROLOGY | MEDIA | INDUCED NEPHROTOXICITY | FAILURE | CREATININE CLEARANCE | RENAL-INSUFFICIENCY | Administration, Intravenous | Contrast Media - adverse effects | Osmolar Concentration | Risk Assessment | Contrast Media - administration & dosage | Humans | Kidney Diseases - chemically induced | Contrast Media - chemistry | Research Design - standards | Control Groups | Angiocardiography
Journal Article
MEDICINE, ISSN 0025-7974, 07/2017, Volume 96, Issue 27, p. e7384
Background: The prophylactic efficacy of statin pretreatment for the prevention of contrast-induced nephropathy (CIN) in patients undergoing coronary...
REACTIVE PROTEIN | contrast-induced nephropathy | ACUTE KIDNEY INJURY | MEDICINE, GENERAL & INTERNAL | percutaneous coronary intervention | STATIN THERAPY | INCREASE | RISK | rosuvastatin | coronary angiography | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Contrast Media - adverse effects | Kidney Diseases - prevention & control | Humans | Kidney Diseases - chemically induced | Coronary Angiography - adverse effects | Percutaneous Coronary Intervention - adverse effects | Rosuvastatin Calcium - administration & dosage | Randomized Controlled Trials as Topic | Antioxidants | Complications and side effects | Usage | Angiography | Dosage and administration | Rosuvastatin | Diabetes
REACTIVE PROTEIN | contrast-induced nephropathy | ACUTE KIDNEY INJURY | MEDICINE, GENERAL & INTERNAL | percutaneous coronary intervention | STATIN THERAPY | INCREASE | RISK | rosuvastatin | coronary angiography | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Contrast Media - adverse effects | Kidney Diseases - prevention & control | Humans | Kidney Diseases - chemically induced | Coronary Angiography - adverse effects | Percutaneous Coronary Intervention - adverse effects | Rosuvastatin Calcium - administration & dosage | Randomized Controlled Trials as Topic | Antioxidants | Complications and side effects | Usage | Angiography | Dosage and administration | Rosuvastatin | Diabetes
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2010, Volume 155, Issue 3, pp. 418 - 423
Abstract Background Contrast-induced nephropathy (CIN) is a leading cause of acute renal failure and affects mortality and morbidity. We investigated the...
Cardiovascular | High-dose hydration | Intravenous N-acetylcysteine | Contrast induced nephropathy | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CORONARY-ANGIOGRAPHY | RENAL-FUNCTION | INSUFFICIENCY | RANDOMIZED CONTROLLED-TRIAL | ORAL ACETYLCYSTEINE | CREATININE | MEDIA | Prospective Studies | Follow-Up Studies | Kidney Diseases - prevention & control | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Free Radical Scavengers - administration & dosage | Male | Treatment Outcome | Coronary Angiography - adverse effects | Coronary Disease - diagnosis | Dose-Response Relationship, Drug | Angioplasty, Balloon, Coronary - adverse effects | Contrast Media - adverse effects | Coronary Angiography - methods | Fluid Therapy - methods | Coronary Disease - therapy | Kidney Diseases - chemically induced | Creatinine - blood | Female | Aged | Kidney Diseases - blood | Infusions, Intravenous | Acetylcysteine - administration & dosage | Prevention | Acetylcysteine | Clinical trials | Dosage and administration | Kidney diseases
Cardiovascular | High-dose hydration | Intravenous N-acetylcysteine | Contrast induced nephropathy | MODERATE | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CORONARY-ANGIOGRAPHY | RENAL-FUNCTION | INSUFFICIENCY | RANDOMIZED CONTROLLED-TRIAL | ORAL ACETYLCYSTEINE | CREATININE | MEDIA | Prospective Studies | Follow-Up Studies | Kidney Diseases - prevention & control | Angioplasty, Balloon, Coronary - methods | Humans | Middle Aged | Free Radical Scavengers - administration & dosage | Male | Treatment Outcome | Coronary Angiography - adverse effects | Coronary Disease - diagnosis | Dose-Response Relationship, Drug | Angioplasty, Balloon, Coronary - adverse effects | Contrast Media - adverse effects | Coronary Angiography - methods | Fluid Therapy - methods | Coronary Disease - therapy | Kidney Diseases - chemically induced | Creatinine - blood | Female | Aged | Kidney Diseases - blood | Infusions, Intravenous | Acetylcysteine - administration & dosage | Prevention | Acetylcysteine | Clinical trials | Dosage and administration | Kidney diseases
Journal Article
Kidney International, ISSN 0085-2538, 04/2006, Volume 69, Issue S100, pp. S11 - S15
Radiological procedures utilizing intravascular iodinated contrast media injections are being widely applied for both diagnostic and therapeutic purposes. This...
epidemiology | contrast induced nephropathy | contrast media | Contrast induced nephropathy | Epidemiology | Contrast media | RADIOCONTRAST-INDUCED NEPHROPATHY | INSUFFICIENCY | ACUTE-RENAL-FAILURE | DIABETES-MELLITUS | SERUM CREATININE | PERCUTANEOUS CORONARY INTERVENTION | HIGH-OSMOLALITY | UROLOGY & NEPHROLOGY | MEDIA | INDUCED NEPHROTOXICITY | CHRONIC KIDNEY-DISEASE
epidemiology | contrast induced nephropathy | contrast media | Contrast induced nephropathy | Epidemiology | Contrast media | RADIOCONTRAST-INDUCED NEPHROPATHY | INSUFFICIENCY | ACUTE-RENAL-FAILURE | DIABETES-MELLITUS | SERUM CREATININE | PERCUTANEOUS CORONARY INTERVENTION | HIGH-OSMOLALITY | UROLOGY & NEPHROLOGY | MEDIA | INDUCED NEPHROTOXICITY | CHRONIC KIDNEY-DISEASE
Journal Article
Circulation: Cardiovascular Interventions, ISSN 1941-7640, 2014, Volume 7, Issue 2, pp. 216 - 224
Background-Contrast-induced nephropathy (CIN) is a serious condition in patients with ST-segment-elevation myocardial infarction treated with primary...
Contrast-Induced Nephropathy | St-Segment-Elevation Myocardial Infarction | MORTALITY | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | ACUTE-RENAL-FAILURE | HYDRATION | contrast-induced nephropathy | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | UNSELECTED PATIENTS | MEDIA | ST-segment-elevation myocardial infarction | PRIMARY ANGIOPLASTY | Sodium Bicarbonate - therapeutic use | Prospective Studies | Kidney Diseases - prevention & control | Humans | Middle Aged | Male | Sodium Bicarbonate - administration & dosage | Treatment Outcome | Incidence | Myocardial Infarction - therapy | Contrast Media - adverse effects | Percutaneous Coronary Intervention - methods | Kidney Diseases - epidemiology | Kidney Diseases - chemically induced | Creatinine - blood | Electrocardiography | Female | Myocardial Infarction - physiopathology | Aged | Acetylcysteine - therapeutic use | Infusions, Intravenous | Acetylcysteine - administration & dosage | Drug Therapy, Combination | Percutaneous Coronary Intervention - adverse effects
Contrast-Induced Nephropathy | St-Segment-Elevation Myocardial Infarction | MORTALITY | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | ACUTE-RENAL-FAILURE | HYDRATION | contrast-induced nephropathy | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | UNSELECTED PATIENTS | MEDIA | ST-segment-elevation myocardial infarction | PRIMARY ANGIOPLASTY | Sodium Bicarbonate - therapeutic use | Prospective Studies | Kidney Diseases - prevention & control | Humans | Middle Aged | Male | Sodium Bicarbonate - administration & dosage | Treatment Outcome | Incidence | Myocardial Infarction - therapy | Contrast Media - adverse effects | Percutaneous Coronary Intervention - methods | Kidney Diseases - epidemiology | Kidney Diseases - chemically induced | Creatinine - blood | Electrocardiography | Female | Myocardial Infarction - physiopathology | Aged | Acetylcysteine - therapeutic use | Infusions, Intravenous | Acetylcysteine - administration & dosage | Drug Therapy, Combination | Percutaneous Coronary Intervention - adverse effects
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 12, pp. 1421 - 1429
Objectives: This study sought to investigate whether the beneficial impact of high-dose rosuvastatin against contrast-induced acute kidney injury (CI-AKI) in...
C-reactive protein | Acute coronary syndromes | Contrast-induced nephropathy | Statins | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | FOLLOW-UP | RISK | PROGNOSTIC VALUE | acute coronary syndromes | contrast-induced nephropathy | STATIN THERAPY | statins | DISEASE | ATORVASTATIN PRETREATMENT | SHORT-TERM | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Multivariate Analysis | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Coronary Angiography - adverse effects | Fluorobenzenes - administration & dosage | Protective Factors | C-Reactive Protein - metabolism | Contrast Media - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Anti-Inflammatory Agents - administration & dosage | Female | Acute Kidney Injury - chemically induced | Odds Ratio | Pyrimidines - administration & dosage | Acute Kidney Injury - blood | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Inflammation Mediators - blood | Rosuvastatin Calcium | Logistic Models | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Acute Kidney Injury - prevention & control | Acute Coronary Syndrome - blood | Acute Kidney Injury - mortality | Acute Kidney Injury - diagnosis | Creatinine - blood | Acute Coronary Syndrome - therapy | Aged | Sulfonamides - administration & dosage
C-reactive protein | Acute coronary syndromes | Contrast-induced nephropathy | Statins | ACUTE KIDNEY INJURY | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | FOLLOW-UP | RISK | PROGNOSTIC VALUE | acute coronary syndromes | contrast-induced nephropathy | STATIN THERAPY | statins | DISEASE | ATORVASTATIN PRETREATMENT | SHORT-TERM | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Multivariate Analysis | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Acute Coronary Syndrome - physiopathology | Male | Coronary Angiography - adverse effects | Fluorobenzenes - administration & dosage | Protective Factors | C-Reactive Protein - metabolism | Contrast Media - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Anti-Inflammatory Agents - administration & dosage | Female | Acute Kidney Injury - chemically induced | Odds Ratio | Pyrimidines - administration & dosage | Acute Kidney Injury - blood | Risk Factors | Acute Coronary Syndrome - diagnostic imaging | Inflammation Mediators - blood | Rosuvastatin Calcium | Logistic Models | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Acute Kidney Injury - prevention & control | Acute Coronary Syndrome - blood | Acute Kidney Injury - mortality | Acute Kidney Injury - diagnosis | Creatinine - blood | Acute Coronary Syndrome - therapy | Aged | Sulfonamides - administration & dosage
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 1, pp. 71 - 79
Objectives This study sought to determine if in addition to standard preventive measures on-admission, high-dose rosuvastatin exerts a protective effect...
Cardiovascular | Internal Medicine | contrast-induced nephropathy | acute coronary syndrome(s) | statins | C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | SERUM CREATININE | GLOMERULAR-FILTRATION-RATE | ANGIOGRAPHY | STATIN THERAPY | CHRONIC KIDNEY-DISEASE | INTERVENTION | SHORT-TERM | CREATININE CLEARANCE | Rosuvastatin | Dosage and administration | Kidney diseases | Coronary heart disease | Public health | Antilipemic agents | Heart attacks | Acute coronary syndromes | Drug therapy | Mortality | Statins
Cardiovascular | Internal Medicine | contrast-induced nephropathy | acute coronary syndrome(s) | statins | C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | SERUM CREATININE | GLOMERULAR-FILTRATION-RATE | ANGIOGRAPHY | STATIN THERAPY | CHRONIC KIDNEY-DISEASE | INTERVENTION | SHORT-TERM | CREATININE CLEARANCE | Rosuvastatin | Dosage and administration | Kidney diseases | Coronary heart disease | Public health | Antilipemic agents | Heart attacks | Acute coronary syndromes | Drug therapy | Mortality | Statins
Journal Article
Investigative Radiology, ISSN 0020-9996, 11/2006, Volume 41, Issue 11, pp. 815 - 821
BACKGROUND:Based on a single clinical trial, it has been suggested that the contrast agent iodixanol, which is isotonic to human plasma, may be less...
Contrastinduced nephropathy | Chronic kidney disease | Computed tomography | Contrast media | Double-Blind Method | Humans | Middle Aged | Triiodobenzoic Acids - administration & dosage | Male | Tomography, X-Ray Computed | Contrast Media - adverse effects | Iopamidol - administration & dosage | Contrast Media - administration & dosage | Kidney Diseases - chemically induced | Iopamidol - adverse effects | Adult | Female | Aged | Kidney Diseases - etiology | Chronic Disease | Triiodobenzoic Acids - adverse effects | computed tomography | chronic kidney disease | CORONARY-ANGIOGRAPHY | RENAL-FUNCTION | PREVENTION | N-ACETYLCYSTEINE | RANDOMIZED CONTROLLED-TRIAL | EUROPEAN-SOCIETY | ORAL ACETYLCYSTEINE | contrast-induced nephropathy | HIGH-RISK PATIENTS | contrast media | MEDIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROTOXICITY
Contrastinduced nephropathy | Chronic kidney disease | Computed tomography | Contrast media | Double-Blind Method | Humans | Middle Aged | Triiodobenzoic Acids - administration & dosage | Male | Tomography, X-Ray Computed | Contrast Media - adverse effects | Iopamidol - administration & dosage | Contrast Media - administration & dosage | Kidney Diseases - chemically induced | Iopamidol - adverse effects | Adult | Female | Aged | Kidney Diseases - etiology | Chronic Disease | Triiodobenzoic Acids - adverse effects | computed tomography | chronic kidney disease | CORONARY-ANGIOGRAPHY | RENAL-FUNCTION | PREVENTION | N-ACETYLCYSTEINE | RANDOMIZED CONTROLLED-TRIAL | EUROPEAN-SOCIETY | ORAL ACETYLCYSTEINE | contrast-induced nephropathy | HIGH-RISK PATIENTS | contrast media | MEDIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NEPHROTOXICITY
Journal Article